NF-κB, which is one of many downstream targets of TNF receptor 1 activation, is likely to play a prominent role in colitis-associated tumorigenesis because aberrant NF-κB activation was detected in > 50% of colorectal and colitis-associated tumors and mouse studies [7]. The gene discussed is NFKB1; the disease is colitis.